7-30612215-T-C

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_002047.4(GARS1):​c.1001T>C​(p.Ile334Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I334M) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

GARS1
NM_002047.4 missense

Scores

14
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 7.93

Publications

0 publications found
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 2D
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • neuronopathy, distal hereditary motor, type 5A
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
  • spinal muscular atrophy, infantile, James type
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_002047.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-30612216-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 931791.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.958
PP5
Variant 7-30612215-T-C is Pathogenic according to our data. Variant chr7-30612215-T-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 958512.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GARS1NM_002047.4 linkc.1001T>C p.Ile334Thr missense_variant Exon 8 of 17 ENST00000389266.8 NP_002038.2
GARS1NM_001316772.1 linkc.839T>C p.Ile280Thr missense_variant Exon 8 of 17 NP_001303701.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GARS1ENST00000389266.8 linkc.1001T>C p.Ile334Thr missense_variant Exon 8 of 17 1 NM_002047.4 ENSP00000373918.3
GARS1ENST00000675651.1 linkc.1001T>C p.Ile334Thr missense_variant Exon 8 of 17 ENSP00000502513.1
GARS1ENST00000675810.1 linkc.899T>C p.Ile300Thr missense_variant Exon 7 of 16 ENSP00000502743.1
GARS1ENST00000675693.1 linkc.833T>C p.Ile278Thr missense_variant Exon 9 of 18 ENSP00000502174.1
GARS1ENST00000675051.1 linkc.800T>C p.Ile267Thr missense_variant Exon 8 of 17 ENSP00000502296.1
GARS1ENST00000674815.1 linkc.632T>C p.Ile211Thr missense_variant Exon 8 of 17 ENSP00000502799.1
GARS1ENST00000674851.1 linkc.632T>C p.Ile211Thr missense_variant Exon 9 of 18 ENSP00000502451.1
GARS1ENST00000444666.6 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 18 3 ENSP00000415447.2
GARS1ENST00000674616.1 linkn.*715T>C non_coding_transcript_exon_variant Exon 9 of 18 ENSP00000502408.1
GARS1ENST00000674643.1 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 17 ENSP00000501636.1
GARS1ENST00000674737.1 linkn.*339T>C non_coding_transcript_exon_variant Exon 9 of 18 ENSP00000502464.1
GARS1ENST00000674807.1 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 16 ENSP00000502814.1
GARS1ENST00000675529.1 linkn.*871T>C non_coding_transcript_exon_variant Exon 9 of 18 ENSP00000501655.1
GARS1ENST00000675859.1 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 15 ENSP00000502033.1
GARS1ENST00000676088.1 linkn.*943T>C non_coding_transcript_exon_variant Exon 10 of 19 ENSP00000501884.1
GARS1ENST00000676140.1 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 17 ENSP00000502571.1
GARS1ENST00000676164.1 linkn.*452T>C non_coding_transcript_exon_variant Exon 8 of 17 ENSP00000501986.1
GARS1ENST00000676210.1 linkn.*290T>C non_coding_transcript_exon_variant Exon 9 of 18 ENSP00000502373.1
GARS1ENST00000676259.1 linkn.*433T>C non_coding_transcript_exon_variant Exon 8 of 17 ENSP00000501980.1
GARS1ENST00000676403.1 linkn.1001T>C non_coding_transcript_exon_variant Exon 8 of 16 ENSP00000502681.1
GARS1ENST00000674616.1 linkn.*715T>C 3_prime_UTR_variant Exon 9 of 18 ENSP00000502408.1
GARS1ENST00000674737.1 linkn.*339T>C 3_prime_UTR_variant Exon 9 of 18 ENSP00000502464.1
GARS1ENST00000675529.1 linkn.*871T>C 3_prime_UTR_variant Exon 9 of 18 ENSP00000501655.1
GARS1ENST00000676088.1 linkn.*943T>C 3_prime_UTR_variant Exon 10 of 19 ENSP00000501884.1
GARS1ENST00000676164.1 linkn.*452T>C 3_prime_UTR_variant Exon 8 of 17 ENSP00000501986.1
GARS1ENST00000676210.1 linkn.*290T>C 3_prime_UTR_variant Exon 9 of 18 ENSP00000502373.1
GARS1ENST00000676259.1 linkn.*433T>C 3_prime_UTR_variant Exon 8 of 17 ENSP00000501980.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 2 Pathogenic:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 334 of the GARS protein (p.Ile334Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of autosomal dominant Charcot-Marie-Tooth disease (internal data). ClinVar contains an entry for this variant (Variation ID: 958512). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GARS protein function with a positive predictive value of 95%. This variant disrupts the p.Ile334 amino acid residue in GARS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17101916, 24604904, 25168514, 25476837). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

not provided Pathogenic:1
Jan 04, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PP3, PM1, PM2, PM5

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.93
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.92
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.60
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Uncertain
0.59
D
PhyloP100
7.9
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-4.5
D
REVEL
Pathogenic
0.85
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Vest4
0.94
ClinPred
1.0
D
GERP RS
5.6
Varity_R
0.93
gMVP
0.85
Mutation Taster
=17/83
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1554338262; hg19: chr7-30651831; API